Literature DB >> 2530284

Characterization of individual tumor necrosis factor alpha-and beta-producing cells after polyclonal T cell activation.

U Andersson1, G Adolf, M Dohlsten, G Möller, H O Sjögren.   

Abstract

Mononuclear cells from human blood were stimulated to tumor necrosis factor alpha (TNF alpha) or beta (TNF beta) production by the T cell mitogens anti-CD3 antibody (OKT3) or staphylococcal enterotoxin A (SEA). The cells were then fixed and subsequently permeabilized in suspension by the detergent saponin in order to enable TNF alpha- or TNF beta-specific antibodies to enter the cells and interact with cytoplasmic TNF in producer cells. A characteristic morphology of the staining pattern of the two cytokines was noted, with a local accumulation in the cytoplasm in a perinuclear position reflecting the presence of TNF alpha or -beta in the Golgi system. TNF alpha-producing cells appeared 2-3 h after activation of the cultures and increased up to 6 h. The majority of these early TNF alpha-producing cells were monocytes as judged by two-color staining and morphology, but a small fraction of CD4- and CD8-positive T cells was found up to 72 h. TNF beta production started later and peaked 18 or 48 h after OKT3 or SEA stimulation, respectively. The number of TNF beta-producing cells was much larger than that of TNF alpha-producing cells, and approximately 90% of them were CD4-positive T cells. The remaining TNF beta production occurred in CD8-positive T cells and in B cells. Almost every second CD4-positive T cell made TNF beta at the peak of the SEA-induced synthesis. The cytotoxic activity found in the supernatants correlated well with the number of TNF-producing cells found in the cultures. Cells from fresh blood or unstimulated cultures showed no or very few TNF-producing cells.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2530284     DOI: 10.1016/0022-1759(89)90227-5

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  14 in total

1.  Alterations in mononuclear cell tumour necrosis factor-alpha (TNF-alpha) response in patients on long term cuprophane haemodialysis.

Authors:  A Y Annenkov; A G Strokov; F S Baranova
Journal:  Clin Exp Immunol       Date:  1992-10       Impact factor: 4.330

2.  Targeting of human cytotoxic T lymphocytes to MHC class II-expressing cells by staphylococcal enterotoxins.

Authors:  M Dohlsten; P A Lando; G Hedlund; J Trowsdale; T Kalland
Journal:  Immunology       Date:  1990-09       Impact factor: 7.397

3.  Detection of cytokine producing cells in the synovial membrane from patients with rheumatoid arthritis.

Authors:  A K Ulfgren; S Lindblad; L Klareskog; J Andersson; U Andersson
Journal:  Ann Rheum Dis       Date:  1995-08       Impact factor: 19.103

4.  Movement disorders in encephalitis induced by Rhodococcus aurantiacus infection relieved by the administration of L-dopa and anti-T-cell antibodies.

Authors:  Y Min; M Asano; M Kohanawa; T Minagawa
Journal:  Immunology       Date:  1999-01       Impact factor: 7.397

5.  Production of tumor necrosis factors alpha and beta by human mononuclear leukocytes stimulated with mitogens, bacteria, and malarial parasites.

Authors:  A Ferrante; R E Staugas; B Rowan-Kelly; S Bresatz; L M Kumaratilake; C M Rzepczyk; G R Adolf
Journal:  Infect Immun       Date:  1990-12       Impact factor: 3.441

6.  Human immunodeficiency virus type 1-specific cytotoxic T lymphocytes release gamma interferon, tumor necrosis factor alpha (TNF-alpha), and TNF-beta when they encounter their target antigens.

Authors:  C Jassoy; T Harrer; T Rosenthal; B A Navia; J Worth; R P Johnson; B D Walker
Journal:  J Virol       Date:  1993-05       Impact factor: 5.103

7.  Persistence of local cytokine production in shigellosis in acute and convalescent stages.

Authors:  R Raqib; A A Lindberg; B Wretlind; P K Bardhan; U Andersson; J Andersson
Journal:  Infect Immun       Date:  1995-01       Impact factor: 3.441

8.  Immunopharmacology of the superantigen staphylococcal enterotoxin A in T-cell receptor V beta 3 transgenic mice.

Authors:  M Dohlsten; M Björklund; A Sundstedt; G Hedlund; D Samson; T Kalland
Journal:  Immunology       Date:  1993-08       Impact factor: 7.397

9.  T cell killing of human colon carcinomas by monoclonal-antibody-targeted superantigens.

Authors:  P A Lando; M Dohlsten; G Hedlund; E Akerblom; T Kalland
Journal:  Cancer Immunol Immunother       Date:  1993       Impact factor: 6.968

10.  Effects of FK506 and cyclosporin A on cytokine production studied in vitro at a single-cell level.

Authors:  J Andersson; S Nagy; C G Groth; U Andersson
Journal:  Immunology       Date:  1992-01       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.